Biofeedback for your brain?

2010-09-09

(Press-News.org) Philadelphia, PA, 9 September, 2010 - There is new evidence that people can learn to control the activity of some brain regions when they get feedback signals provided by functional magnetic resonance brain imaging (fMRI).

Dr. Andrea Caria and colleagues used this specialized imaging technique during training sessions in three groups of healthy participants who were asked to assess visual emotional stimuli (negative or neutral pictures). The scientists were interested in the signals generated by the insula, a brain region implicated in emotion regulation. While performing the test, the investigators provided the subjects with specific, unspecific, or no feedback about the extent of the activation of the insula.

They found that the individuals who received specific feedback were able to successfully increase the activity of the insula and perceived the negative pictures as being more unpleasant. The reverse was also true, i.e., when the insula's level of activity was decreased, a reduced sensitivity to negative stimuli was observed.

The two other groups, who received unspecific or no feedback, were not able to enhance insula activity and showed no changes in subjective emotional responses.

The lead author, Dr. Andrea Caria, commented, "Our study demonstrates that voluntary control of emotionally important brain systems is possible. More importantly, after learning to voluntarily regulate the insula, the participants experienced emotionally negative material as more aversive than before training.

This means that individuals can modify their perception to aversive stimuli."

"This technique may provide a mechanism to obtain some measure of voluntary control over the activity of particular brain regions, and thus mental processes, that are typically beyond our reach. It may open new avenues for cognitive and behavioral therapies," added Dr. John Krystal, Editor of Biological Psychiatry.

The authors agree, noting that their findings may be relevant for the development of novel approaches for the clinical treatment of emotional disorders such as antisocial behavior or social phobia which have shown hypoactivity and overactivity, respectively, in the insular region. However, more research is necessary before such treatments may become available.

###

Notes to Editors

The article is "Volitional Control of Anterior Insula Activity Modulates the Response to Aversive Stimuli. A Real-Time Functional Magnetic Resonance Imaging Study" by Andrea Caria, Ranganatha Sitaram, Ralf Veit, Chiara Begliomini, and Niels Birbaumer. Caria, Sitaram, Veit, and Birbaumer are affiliated with the Institute of Medical Psychology and Behavioral Neurobiology, Eberhard-Karls-University of Tübingen, Tübingen, Germany. Caria is also from the Department of Cognitive Science, University of Trento, Trento, Italy. Veit is also with the Max Planck Institute for Biological Cybernetics, Tübingen, Germany. Birbaumer is also from the Ospedale San Camillo, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico, Venezia, Italy. Begliomini is affiliated with the Dipartimento di Scienze Biomediche e Terapie Avanzate, Section of Human Physiology, University of Ferrara, Ferrara, Italy. The article appears in Biological Psychiatry, Volume 68, Issue 5 (September 1, 2010), published by Elsevier.

The authors' disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D. is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available at http://journals.elsevierhealth.com/webfiles/images/journals/bps/Biological-Psychiatry-Editorial-Disclosures-7-22-10.pdf.

Full text of the article mentioned above is available upon request. Contact Chris J. Pfister at c.pfister@elsevier.com to obtain a copy or to schedule an interview.

About Biological Psychiatry

This international rapid-publication journal is the official journal of the Society of Biological Psychiatry. It covers a broad range of topics in psychiatric neuroscience and therapeutics. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and treatment of major neuropsychiatric disorders. Full-length and Brief Reports of novel results, Commentaries, Case Studies of unusual significance, and Correspondence and Comments judged to be of high impact to the field are published, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Concise Reviews and Editorials that focus on topics of current research and interest are also published rapidly.

Biological Psychiatry (www.sobp.org/journal) is ranked 4th out of 117 Psychiatry titles and 13th out of 230 Neurosciences titles in the 2009 ISI Journal Citations Reports® published by Thomson Reuters. The 2009 Impact Factor score for Biological Psychiatry has increased to 8.926.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

END

ELSE PRESS RELEASES FROM THIS DATE:

Carnegie Mellon researchers develop method to help computer vision systems decipher outdoor scenes

2010-09-09

PITTSBURGH—Computer vision systems can struggle to make sense of a single image, but a new method devised by computer scientists at Carnegie Mellon University enables computers to gain a deeper understanding of an image by reasoning about the physical constraints of the scene. In much the same way that a child might use a set of toy building blocks to assemble something that looks like a building depicted on the cover of the toy set, the computer would analyze an outdoor scene by using virtual blocks to build a three-dimensional approximation of the image that makes sense ...

High stress hormone levels linked to increased cardiovascular mortality

2010-09-09

Chevy Chase, MD—High levels of the stress hormone cortisol strongly predict cardiovascular death among both persons with and without pre-existing cardiovascular disease according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). In stressful situations, the body responds by producing the hormone cortisol. The effects of cortisol are intended to help the body recover from stress and regain a status of homeostasis, however chronically elevated cortisol levels have been associated with cardiovascular ...

Appetite hormones may predict weight regain after dieting

2010-09-09

Chevy Chase, MD—Many people have experienced the frustration that comes with regaining weight that was lost from dieting. According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), the levels of appetite hormones in the body prior to dieting may serve as a predictor of weight regain after dieting. "Treating obesity with drugs or dietary programs can be very effective in the short-term, but the long-term success of maintaining the weight lost is usually poor," said Ana Crujeiras, PhD, of Compejo Hospitalario ...

Drug-resistant malaria suggests a health policy change for pregnant women and infants

2010-09-09

September 9, 2010 – Malaria remains a serious global health problem, killing more than one million people per year. Treatment of the mosquito-borne illness relies on antibiotics, and the emergence of drug-resistant malaria is of growing concern. In a report published online today in Genome Research (www.genome.org), scientists analyzed the genomic features of a Peruvian parasite population, identifying the genetic basis for resistance to a common antibiotic and gaining new insights that could improve the efficacy of diagnosis and treatment strategies. The World Health ...

Researchers design more accurate method of determining premature infants' risk of illness

2010-09-09

STANFORD, Calif. - Stanford University researchers have developed a revolutionary, non-invasive way of quickly predicting the future health of premature infants, an innovation that could better target specialized medical intervention and reduce health-care costs. "What the PhysiScore does is open a new frontier," said Anna Penn, MD, PhD, an assistant professor of pediatrics at the School of Medicine and a neonatologist at Lucile Packard Children's Hospital. "The national push toward electronic medical records helped us create a tool to detect patterns not readily ...

Researchers identify genes tied to deadliest ovarian cancers

2010-09-09

Scientists at the Johns Hopkins Kimmel Cancer Center have identified two genes whose mutations appear to be linked to ovarian clear cell carcinoma, one of the most aggressive forms of ovarian cancer. Clear cell carcinoma is generally resistant to standard therapy. In an article published online in the September 8 issue of Science Express, the researchers report that they found an average of 20 mutated genes per each ovarian clear cell cancer studied. Two of the genes were more commonly mutated among the samples: ARID1A, a gene whose product normally suppresses tumors; ...

Study identifies critical 'traffic engineer' of the nervous system

2010-09-09

Athens, GA—A new University of Georgia study published in the journal Nature has identified a critical enzyme that keeps traffic flowing in the right direction in the nervous system, and the finding could eventually lead to new treatments for conditions such as Alzheimer's and Parkinson's disease. "There was no medical or any other applied science drive for this project; it was purely curiosity about how transport inside cells works," said study co-author Jacek Gaertig, professor in the cellular biology department in the UGA Franklin College of Arts and Sciences. "But ...

Novel sensing mechanism discovered in dendritic cells to increase immune response to HIV

2010-09-09

New York, NY (September 8, 2010) – Dendritic cells are the grand sentinels of the immune system, standing guard 24/7 to detect foreign invaders such as viruses and bacteria, and bring news of the invasion to other immune cells to marshal an attack. These sentinels, however, nearly always fail to respond adequately to HIV, the virus causing AIDS. Now a team of scientists at NYU Langone Medical Center has discovered a sensor in dendritic cells that recognizes HIV, spurring a more potent immune response by the sentinels to the virus. They report their findings in the September ...

House-sharing with microbes

2010-09-09

Household dust contains up to 1000 different species of microbes, with tens of millions of individual bacterial cells in each gram. And these are just the ones that can be grown in the lab! Dr Helena Rintala, speaking at the Society for General Microbiology's autumn meeting in Nottingham describes how we share our living and working spaces with millions of microbes, not all of whom are bad news. Microbes are a part of our normal environment and can be both beneficial and detrimental to our health. "Exposure to microbes in childhood can prevent the development of allergies. ...

Yeast holds clues to Parkinson's disease

2010-09-09

Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today. Dr Tiago Fleming Outeiro from the Instituto de Medicina Molecular in Lisbon, Portugal describes how his group is slowly uncovering the molecular basis of Parkinson's disease by studying the associated human protein in yeast cells. Parkinson's disease is a neurodegenerative disorder without any known cure that affects around 6 million people worldwide. The ...

Biofeedback for your brain?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: